Colorectal Metastasis Prevention International Trial 2

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 28, 2019

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Colorectal Neoplasms
Interventions
DRUG

Propranolol and etodolac

A perioperative combined drug regimen

OTHER

Placebo

Placebo

Trial Locations (6)

45858

NOT_YET_RECRUITING

Sheba Medical Center, Tel Litwinsky

70300

RECRUITING

Asaf Harofeh Medical Center, Ẕerifin

1834111

NOT_YET_RECRUITING

HaEmek Medical Center, Afula

3109601

NOT_YET_RECRUITING

Rambam Health Care Campus, Haifa

4941492

NOT_YET_RECRUITING

Rabin Medical Center, Petah Tikva

6423906

NOT_YET_RECRUITING

Sourasky Medical Center, Tel Aviv

All Listed Sponsors
collaborator

Sheba Medical Center

OTHER_GOV

collaborator

Rabin Medical Center

OTHER

collaborator

Tel-Aviv Sourasky Medical Center

OTHER_GOV

collaborator

Rambam Health Care Campus

OTHER

collaborator

HaEmek Medical Center, Israel

OTHER

lead

Assaf-Harofeh Medical Center

OTHER_GOV